Literature DB >> 32960137

Availability Versus Utilization of Supplemental Breast Cancer Screening Post Passage of Breast Density Legislation.

Mary W Marsh1, Thad S Benefield1, Sheila Lee1, Michael Pritchard1, Katie Earnhardt1, Robert Agans2, Louise M Henderson1,3.   

Abstract

Objective: Despite the lack of evidence that supplemental screening in women with dense breasts reduces breast cancer mortality, 38 states have passed breast density legislation, with some including recommendations for supplemental screening. The objective of this study is to compare the availability versus use of supplemental breast cancer screening modalities and determine factors driving use of supplemental screening in rural versus urban settings.
Methods: A 50-item mailed survey using the Tailored Design Method was sent to American College of Radiology mammography-accredited facilities in North Carolina in 2017. Respondents included 94 facilities (48 rural and 46 urban locations). Survey questions focused on breast cancer and supplemental screening services, breast density, risk factors/assessment, and facility demographics.
Results: The survey response rate was 60.3% (94/156). Among the 94 respondents, 64.0% (n = 60) reported availability of any type of supplemental screening (digital breast tomosynthesis [DBT], ultrasound, or magnetic resonance imaging [MRI]). In facilities where supplemental screening modalities were available, the most commonly utilized supplemental screening modality was DBT (96.4%), compared with ultrasound (35.7%) and MRI (46.7%). Facilities reported using supplemental screening based on patient breast density (48.3%), referring physician recommendation (63.3%), reading radiologist recommendation (63.3%), breast cancer risk factors (48.3%), and patient request (40.0%). Urban facilities were more likely than rural facilities to base supplemental screening on breast cancer risk factors (62.5% vs. 32.1%; p-value = 0.019), referring physician (75.0% vs. 50.0%; p-value = 0.045), and reading radiologist (78.1% vs. 46.4%; p-value = 0.011).
Conclusion: In our study, supplemental screening modalities were widely available, with facilities more likely to use DBT for supplemental screening compared to other modalities.

Entities:  

Keywords:  breast cancer screening; breast density; breast density legislation; supplemental breast cancer screening

Mesh:

Year:  2020        PMID: 32960137      PMCID: PMC8064958          DOI: 10.1089/jwh.2020.8528

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  33 in total

1.  Mammographic density and the risk and detection of breast cancer.

Authors:  Norman F Boyd; Helen Guo; Lisa J Martin; Limei Sun; Jennifer Stone; Eve Fishell; Roberta A Jong; Greg Hislop; Anna Chiarelli; Salomon Minkin; Martin J Yaffe
Journal:  N Engl J Med       Date:  2007-01-18       Impact factor: 91.245

2.  Breast Density Legislation in New England: A Survey Study of Practicing Radiologists.

Authors:  Ana P Lourenco; Roberta M DiFlorio-Alexander; Priscilla J Slanetz
Journal:  Acad Radiol       Date:  2017-05-08       Impact factor: 3.173

Review 3.  Digital breast tomosynthesis (3D-mammography) screening: A pictorial review of screen-detected cancers and false recalls attributed to tomosynthesis in prospective screening trials.

Authors:  Nehmat Houssami; Kristina Lång; Daniela Bernardi; Alberto Tagliafico; Sophia Zackrisson; Per Skaane
Journal:  Breast       Date:  2016-02-18       Impact factor: 4.380

Review 4.  Risk-based Breast Cancer Screening: Implications of Breast Density.

Authors:  Christoph I Lee; Linda E Chen; Joann G Elmore
Journal:  Med Clin North Am       Date:  2017-07       Impact factor: 5.456

5.  Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR.

Authors:  Debra L Monticciolo; Mary S Newell; Linda Moy; Bethany Niell; Barbara Monsees; Edward A Sickles
Journal:  J Am Coll Radiol       Date:  2018-01-19       Impact factor: 5.532

6.  Breast cancer screening with digital breast tomosynthesis.

Authors:  Per Skaane
Journal:  Breast Cancer       Date:  2016-04-30       Impact factor: 4.239

7.  Impact of Breast Density Legislation on Breast Cancer Risk Assessment and Supplemental Screening: A Survey of 110 Radiology Facilities.

Authors:  Lina Nayak; Kanae K Miyake; Jessica W T Leung; Elissa R Price; Yueyi I Liu; Bonnie N Joe; Edward A Sickles; William R Thomas; Jafi A Lipson; Bruce L Daniel; Jonathan Hargreaves; R James Brenner; Lawrence W Bassett; Haydee Ojeda-Fournier; Karen K Lindfors; Stephen A Feig; Debra M Ikeda
Journal:  Breast J       Date:  2016-06-14       Impact factor: 2.431

Review 8.  Digital breast tomosynthesis (DBT): a review of the evidence for use as a screening tool.

Authors:  Fiona J Gilbert; Lorraine Tucker; Ken C Young
Journal:  Clin Radiol       Date:  2015-12-23       Impact factor: 2.350

9.  The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening.

Authors:  Nehmat Houssami; Kylie Hunter
Journal:  NPJ Breast Cancer       Date:  2017-04-13

10.  Patient and Provider Perspectives on Mammographic Breast Density Notification Legislation.

Authors:  Elissa V Klinger; Celia P Kaplan; Stella St Hubert; Robyn L Birdwell; Jennifer S Haas
Journal:  MDM Policy Pract       Date:  2016-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.